PE: assessed by CT arteriography ( · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in PE: assessed by CT arteriography ( compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Asymptomatic DVT · adults undergoing KA
It is very uncertain whether low‐molecular‐weight heparin changes asymptomatic DVT: compared with no prophylaxis (very low certainty).
1 finding from 1 review
All‐cause mortality ( · adults undergoing KA
1 finding from 1 review
All adverse effects, including allergies at injection site, minor and major bleeding, others ( · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in all adverse effects, including allergies at injection site, minor… compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Major bleeding · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in major bleeding ( compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Minor bleeding · adults undergoing KA
Low‐molecular‐weight heparin showed no clear difference in minor bleeding ( compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Intervention not reported
Primary outcomes · patients with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary seizure prophylaxis after stroke · patients with stroke
The intervention showed no clear difference in primary seizure prophylaxis after stroke (moderate certainty).
1 finding from 1 review
Intervention not reported
Secondary seizure prophylaxis after stroke · patients with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Secondary outcomes · patients with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Proportion of participants who had died or become dependent at the end of the scheduled · patients with stroke
The intervention showed no clear difference in proportion of participants who had died or become dependent at the… (moderate certainty).
1 finding from 1 review
Intervention not reported
NIHSS from admission for SICH to 12 months · patients with stroke
1 finding from 1 review
Disease severity · children aged up to 16 years with ARTIs
1 finding from 1 review
Adverse events · children aged up to 16 years with ARTIs
It is very uncertain whether homeopathic medicinal products (non‐individualised treatment) changes adverse events compared with placebo or usual care (very low certainty).
1 finding from 1 review
Short‐term cure1 · children aged up to 16 years with ARTIs
It is very uncertain whether homeopathic medicinal products changes short‐term cure1 compared with placebo or usual care (very low certainty).
1 finding from 1 review
Long‐term cure1 · children aged up to 16 years with ARTIs
It is very uncertain whether homeopathic medicinal products changes long‐term cure1 compared with placebo or usual care (very low certainty).
1 finding from 1 review
Disease severity( · children aged up to 16 years with ARTIs
1 finding from 1 review
Recurrence of ARTI · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Days off work for parents · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for antibiotics · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found